Edarbi is a prescription medication classified as an angiotensin ii type 1 receptor blocker used to treat high blood pressure. Its active ingredient valsartan works by blocking the receptors that normally respond to angiotensin ii a hormone that constricts blood vessels. By preventing this constriction the drug helps blood vessels relax and reduces the resistance to blood flow. This relaxation lowers systemic vascular resistance and leads to a decrease in arterial pressure. The reduction in blood pressure eases the workload on the heart and helps protect organs such as the kidneys from damage. Valsartan also blocks angiotensin ii mediated aldosterone secretion which further decreases fluid retention and sodium reabsorption. The combined effects result in a sustained improvement in blood pressure control and cardiovascular protection.

Edarbi is a prescription drug that belongs to the class of angiotensin ii receptor blockers used primarily to treat high blood pressure. It works by blocking the action of angiotensin ii at the at1 receptor, which leads to relaxation of blood vessels. The medication is a prodrug that is metabolized in the liver to azilsartan, the active compound that binds selectively to the receptor. This receptor blockade reduces vasoconstriction and the release of aldosterone, helping the kidneys excrete sodium and water. The combined effect lowers systemic blood pressure and improves cardiac workload without affecting heart rate directly. Through these mechanisms Edarbi provides effective hypertension control with a once-daily dosing schedule.

Edarbi is a prescription medication used to control high blood pressure. Common side effects include dizziness and headache. Some patients may experience low blood pressure or fatigue. Less frequent effects can involve cough or swelling of the ankles. Rarely, changes in kidney function have been reported. These reactions are generally mild and can differ among individuals.

Dizziness may occur especially after the first dose of Edarbi. Some patients experience fatigue and a need for rest during treatment. Headache is a common complaint reported in clinical studies. A dry cough can develop without any sign of infection. Swelling of the ankles or feet may appear due to fluid retention. Elevated potassium levels can be detected in blood tests. Low blood pressure may result from the medication's effect on blood vessels.